Treatment modalities of non-ST-elevation acute coronary syndromes in the real world. Results of the prospective R.OS.A.I.-2 registry

Italian Heart Journal

Volumn 4, Issue 11, 2003, Pages 782-790

  De Servi, Stefano ^a   Cavallini, Claudio ^b   Dellavalle, Antonio ^c   Santoro, Giovanni Maria ^d   Bonizzoni, Erminio ^e   Marzocchi, Antonio ^f   Politi, Alesandro ^g   Pesaresi, Antonio ^h   Chierchia, Sergio ⁱ   Semprini, F ^j   Scaramuzzino, G ^j   Pinelli, G ^j   Pancaldi, L ^j   Antenucci, C ^j   Ongari, M ^j   Fantini, G ^j   Ricci, S ^j   Melandri, F ^j   Maresta, A ^j   Percoco, G ^j   Manari, A ^j   Di Stefano, S ^j   Violi, E ^j   Gambarati, G ^j   Rolli, A ^j   Galvani, M ^j   Bruna, C ^j   Doronzo, B ^j   Matta, S ^j   Bellone, E ^j   Conte, M R ^j   Pesaresi, A ^j   Gandolfo, N ^j   Paolillo, V ^j   De Leo, A ^j   Barbieri, E ^j   Canali, G ^j   Palatini, O ^j   Bilardo, G ^j   Biondi, P ^j   Neri, R ^j   Zuin, G ^j   Ragazzo, M ^j   Maras, P ^j   Cassin, M ^j   Fontebasso, A ^j   Pescoler, F ^j   Bonmassari, R ^j   Oberlechner, W ^j   Fontanelli, A ^j   Libardoni, M ^j   Rigatelli, G ^j   Baratello, M C ^j   Delfino, R ^j   Della Rovere, F ^j   Camerieri, A ^j   Miccoli, F ^j   Antoniucci, D ^k   Carabba, N ^k   Conti, A ^l   Battelli, L ^j   Fantini, A ^j   Querceto, L ^j   Naldoni, A ^j   Leoncini, M ^j   Bonechi, F ^j   Pesola, A ^j   Robiglio, L ^j   Galli, M ^j   Genovesi, A ^j   Addonisio, L ^j   Taddei, M ^j   Mariani, M ^j   Formentini, A ^j   Lombroso, G ^j   Zanini, R ^j   Izzo, A ^j   Cattabiani, A ^j   Rosiello, R ^j   Canale, G ^j   Simeoni, L ^j   Lettino, M ^j   Villani, R ^j   Osti, R ^j   Orlandi, M ^j   Bonatti, R ^j   Santarone, M ^j   Procopio, L ^j   Repetto, S ^j   Cuccia, C ^j   Bonini, E ^j   Bortolini, F ^j   Rodella, P ^j   more..

^a Ospedale Civile   (Italy)

^b OSPEDALE CA FONCELLO   (Italy)

^c S CROCE E CARLE HOSPITAL   (Italy)

^d Ospedale di Torregalli   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

^f UNIVERSITY OF BOLOGNA   (Italy)

^g SANT ANNA HOSPITAL   (Italy)

^h Ospedale Infermi   (Italy)

ⁱ UNIVERSITY OF GENOA   (Italy)

^j UTIC ^*

^k UTIC   (Italy)

^l DEU   (Italy)

more..

Author keywords

Acute coronary syndromes; Glycoprotein IIb IIIa inhibitors

Indexed keywords

ANTITHROMBOCYTIC AGENT; BIOLOGICAL MARKER; CREATINE KINASE; CREATINE KINASE MB; FIBRINOGEN RECEPTOR; ISOENZYME; TROPONIN I; TROPONIN T;

ACUTE DISEASE; AGE; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY CARE UNIT; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART STROKE VOLUME; HOSPITAL ADMISSION; HUMAN; ITALY; MALE; MIDDLE AGED; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; PHYSIOLOGY; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; RADIOGRAPHY; REGISTER; SYNDROME; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ACUTE DISEASE; AGE FACTORS; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; COMBINED MODALITY THERAPY; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY CARE UNITS; CORONARY DISEASE; CREATINE KINASE; CREATINE KINASE, MB FORM; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISOENZYMES; ITALY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT ADMISSION; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REGISTRIES; STROKE VOLUME; SYNDROME; TREATMENT OUTCOME; TROPONIN I; TROPONIN T;

EID: 2142686086     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. The CAPTURE Investigators. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study. Lancet 1997; 349: 1429-35.
2. The Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. N Engl J Med 1998; 338: 1488-97.
3. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. The PURSUIT Trial Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy. N Engl J Med 1998; 339: 436-43.
4. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK, for the Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001; 345: 494-502.
5. Mehta SR, Yusuf S, Peters RJ, et al, for the Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) Trial Investigators. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001; 358: 527-33.
6. Steinhubl SR, Berger PB, Mann JT III, et al, on behalf of the Clopidogrel for the Reduction of Events During Observation (CREDO) Investigators. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002; 288: 2411-20.
7. Boersma E, Harrington RA, Moliterno DJ, et al. Platelet glycoprotein IIb/ IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. Lancet 2002; 359: 189-98.
8. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators. Lancet 1999; 354: 708-15.
9. Cannon CP, Weintraub WS, Demopoulos LA, et al, for the TACTICS (Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy)-Thrombolysis in Myocardial Infarction 18 Investigators. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001; 344: 1879-87.
10. Fox KA, Poole-Wilson PA, Henderson RA, et al, for the Randomised Intervention Trial of unstable Angina Investigators. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Lancet 2002; 369: 743-51.
11. Spacek R, Widimsky P, Straka Z, et al. Value of first day angiography/ angioplasty in evolving non-ST segment elevation myocardial infarction: an open multicenter randomized trial. The VINO study. Eur Heart J 2002; 23: 230-8.
12. Bertrand ME, Simoons ML, Fox KA, et al, for the Task Force on the Management of Acute Coronary Syndromes of the European Society of Cardiology. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2002; 23: 1809-40.
13. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: execute summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the management of patients with unstable angina). Circulation 2000; 102: 1193-209.
14. Lee PY, Alexander KP, Hammill BG, Pasquali SK, Peterson ED. Representation of elderly persons and women in published randomized trials of acute coronary syndromes. JAMA 2001; 286: 708-13.
15. Antman EM, Cohen M, Bernink PJ, et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 2000; 284: 835-42.
16. Fox KA, Cokkinos DV, Deckers J, Kell U, Maggioni A, Steg G. The ENACT study: a pan-European survey of acute coronary syndromes. European Network for Acute Coronary Treatment. Eur Heart J 2000; 21: 1440-9.
17. Hasdai D, Behar S, Wallentin L, et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin. The Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur Heart J 2002; 23: 1190-201.
18. Collinson J, Flather MD, Fox KA, et al. Clinical outcomes, risk stratification and practice patterns of unstable angina and myocardial infarction without ST elevation: Prospective Registry of Acute Ischaemic Syndromes in the UK (PRAIS-UK). Eur Heart J 2000; 21: 1450-7.
19. Maggioni AP, Schweiger C, Tavazzi L, et al, on behalf of the EARISA Investigators. Epidemiologic study of use of resources in patients with unstable angina: the EARISA registry. Epidemiologia dell'Assorbimento di Risorse nell'Ischemia, Scompenso e Angina. Am Heart J 2000; 140: 253-63.
20. Savonitto S, Granger CB, Ardissino D, et al, for the GUSTO-IIb Investigators. The prognostic value of creatine kinase elevations extends across the whole spectrum of acute coronary syndromes. J Am Coll Cardiol 2002; 39: 22-9.
21. Lindahl B, Diderholm E, Lagerqvist B, Venge P, Wallentin L, for the FRISC II (Fast Revascularization during InStability in CAD) Investigators. Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy. J Am Coll Cardiol 2001; 38: 979-86.
22. Antman EM. Troponin measurements in ischemic heart disease: more than just a black and white picture. J Am Coll Cardiol 2001; 38: 987-90.
23. Fox KA, Goodman SG, Klein W, et al. Management of acute coronary syndromes. Variations in practice and outcome findings from the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2002; 23: 1177-89.
24. Budaj A, Yusuf S, Mehta SR, et al, for the Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) Trial Investigators. Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups. Circulation 2002; 106: 1622-6.